Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation

Journal of Immunology

Volumn 162, Issue 7, 1999, Pages 4037-4044

  Ford, Gregory S ^a   Barnhart, Bryan ^a   Shone, Scott ^a   Covey, Lori R ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 39; IONOMYCIN; MESSENGER RNA; MONOCLONAL ANTIBODY CD3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE INDUCTION; HELPER CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; RNA ANALYSIS; T LYMPHOCYTE ACTIVATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELLS, CULTURED; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HALF-LIFE; HUMANS; IONS; KINETICS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0033120524     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J. P. Galizzi, C. van Kooten, Y. J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881.
2. Foy, T. M., A. Aruffo, J. Bajorath, J. E. Buhlmann, and R. J. Noelle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591.
3. Grewal, I. S., J. Xu, and R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617.
4. Mohan, C., Y. Shi, J. D. Laman, and S. K. Datta. 1995. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154:1470.
5. Desai-Mehta, A., L. Lu, R. Ramsey-Goldman, and S. K. Datta. 1996. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97:2063.
6. Lane, P., A. Traunecker, S. Inui, A. Lanzavecchia, and D. Gray. 1992. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur. J. Immunol. 22:2573.
7. + T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med. 175:1091.
8. Castle, B. E., K. Kishimoto, C. Stearns, M. L. Brown, and M. R. Kehry. 1993. Regulation of expression of the ligand for CD40 on T helper lymphocytes. J. Immunol. 151:1777.
9. de Boer, M., A. Dasran, J. Kwekkeboom, H. Walter, P. Vandenberghe, and J. L. Ceupens. 1993. Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells. Eur. J. Immunol. 23:3120.
10. Hermann, P., D. Blanchard, B. de Saint-Vis, F. Fossiez, C. Gaillard, B. Vanbervliet, F. Briere, J. Banchereau, and J.-P. Galizzi. 1993. Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes. Eur. J. Immunol. 23:961.
11. Klaus, S. J., L. M. Pinchuk, H. D. Ochs, C.-L. Law, W. C. Fanslow, R. J. Armitage, and E. A. Clark. 1994. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J. Immunol. 152: 5643.
12. Yellin, M. J., K. Sippel, G. Inghirami, L. R. Covey, J. J. Lee, J. Sinning, E. A. Clark, L. Chess, and S. Lederman. 1994. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/ CD40-L. J. Immunol. 152:598.
13. van Kooten, C., C. Gaillard, J.-P. Galizzi, P. Hermann, F. Fossiez, J. Banchereau, and D. Blanchard. 1994. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur. J. Immunol. 24:787.
14. Nusslein, H. G., K.-H. Frosch, W. Woith, P. Lane, J. R. Kalden, and B. Manger. 1996. Increase of intracellular calcium is the essential signal for the expression of CD40 ligand. Eur. J. Immunol. 26:846.
15. + T cells with dendritic cells. Eur. J. Immunol. 26:3137.
16. Roy, M., A. Aruffo, J. A. Ledbetter, P. Linsley, M. Kehry, and R. Noelle. 1994. Studies on the independence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596.
17. Kwekkeboom, J., D. de Rijk, A. Kasran, S. Barcy, C. de Groot, and M. de Boer. 1994. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction. Eur. J. Immunol. 24:508.
18. Jaiswal, A. E., C. Dubey, S. L. Swain, and M. Croft. 1996. Regulation of CD40-ligand expression on naive CD4 T cells: a role for T cell receptor but not co-stimulatory signals. Int. Immunol. 8:275.
19. Peltz, S. W., G. Brewer, P. Berstein, P. A. Hart, and J. Ross. 1991. Regulation of mRNA turnover in eukaryotic cells. Crit. Rev. Eukaryot. Gene Expr. 1:99.
20. Lindsten, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
21. English, B. K., W. M. Weaver, and C. B. Wilson. 1991. Differential regulation of lymphotoxin and tumor necrosis factor genes in human T lymphocytes. J. Biol. Chem. 266:7108.
22. Millet, I., and N. H. Ruddle. 1994. Differential regulation of lymphotoxin (LT), lymphotoxin-b (LT-b), and TNF-α in murine T cell clones activated through the TCR. J. Immunol. 152:4336.
23. Gillis, P., and J. S. Malter. 1991. The adenosine-uridine binding factor recognizes the au-rich elements of cytokine, lymphokine, and oncogene mRNAs. J. Biol. Chem. 266:3172.
24. Stoecklin, G., S. Hahn, and C. Moroni. 1994. Functional hierarchy of AUUUA motifs in mediating rapid interleukin-3 mRNA decay. J. Biol. Chem. 269:28591.
25. Bohjanen, P. R., B. Petryniak, C. H. June, C. B. Thompson, and T. Lindsten. 1991. An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3′ untranslated region of lymphokine mRNA. Mol. Cell. Biol. 11: 3288.
26. Jain, R. G., L. G. Andrews, K. M. McGowan, P. H. Pekala, and J. D. Keene. 1997. Ectopic expression of Hel-N1, and RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes. Mol. Cell. Biol. 17:954.
27. Ma, W. J., S. Cheng, C. Campbell, A. Wright, and H. Furneaux. 1996. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem. 271:8144.
28. Fan, X. C., V. E. Myer, and J. A. Steitz. 1997. AU-rich elements target small nuclear RNAs as well as mRNAs for rapid degradation. Genes Dev. 11:2557.
29. Myer, V. E., X. C. Fan, and J. A. Steitz. 1997. Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. EMBO J. 16:2130.
30. + T cells mediating identity with the CD40-ligand. Mol. Immunol. 31:471.
31. Wilson, G. M., and R. G. Deeley. 1995. An episomal expression vector system for monitoring sequence-specific effects on mRNA stability in human cell lines. Plasmid 33:198.
32. Thompson, C. B., T. Lindsten, J. A. Ledbetter, S. L. Kunkel, H. A. Young, S. G. Emerson, J. M. Leiden, and C. H. June. 1989. CD28 activation pathway regulates the production of multiple T-cell derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86:1333.
33. Gimmi, C. D., G. J. Freeman, J. G. Gribben, K. Sugita, A. S. Freedman, C. Morimoto, and L. M. Nadler. 1991. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88:6575.
34. Sung, S., J. Bjorndahl, C. Wang, H. Kao, and S. Fu. 1988. Production of tumor necrosis factor by human T-cell lines and peripheral blood T-lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J. Exp. Med. 167:937.
35. Sung, S., J. Walters, J. Hudson, and J. Gimball. 1991. Tumor necrosis factor α mRNA accumulation in human milo-monocytic cell lines: role of transcriptional regulation by DNA sequence motifs and mRNA stabilization. J. Immunol. 147: 2047.
36. + T cells. J. Immunol. 151:2497.
37. Wodnar-Filipowicz, A., and C. Moroni. 1990. Regulation of interleukin 3 mRNA expression in mast cells occurs at the post transcriptional level and is mediated by calcium ions. Proc. Natl. Acad. Sci. USA 87:777.
38. Bill, O., C. G. Garlisi, D. S. Grove, G. E. Holt, and A. M. Mastro. 1994. IL-2 mRNA levels and degradation rates change with mode of stimulation and phorbol ester treatment of lymphocytes. Cytokine 6:102.
39. Ohh, M., C. A. Smith, C. Carpenito, and F. Takei. 1994. Regulation of intercellular adhesion molecule-1 gene expression involves multiple mRNA stabilization mechanisms: effects of interferon-γ and phorbol myristate acetate. Blood 84: 2632.
40. Santis, A. G., M. Lopez-Cabrera, F. Sanchez-Madrid, and N. Proudfoot. 1995. Expression of the early lymphocyte activation antigen CD69, a C-type lectin, is regulated by mRNA degradation associated with AU-rich sequence motifs. Eur. J. Immunol. 25:2142.
41. 2+-induced transcription followed by mRNA stabilization through activation of protein kinase C or increase in cAMP. Eur. J. Immunol. 25:889.
42. Graves, R. A., N. B. Pandey, N. Chodchoy, and W. F. Marzluff. 1987. Translation is required for regulation of histone mRNA degradation. Cell 48:615.
43. Parker, R., and A. Jacobsen. 1990. Translation and a 42-nucleotide segment within the mRNA encoded by the yeast MATa1 gene are involved in promoting rapid mRNA decay. Proc. Natl. Acad. Sci. USA 87:2780.
44. Savant-Bhonsale, S., and D. W. Cleveland. 1992. Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a > 20S degradation complex. Genes Dev. 6:1927.
45. Aharon, T., and R. J. Schneider. 1993. Selective destabilization of short-lived mRNAs with the granulocyte-macrophage colony-stimulating factor AU-rich 3′ noncoding region is mediated by a cotranslational mechanism. Mol. Cell. Biol. 13:1971.
46. Curatola, A. M., M. S. Nadal, and R. J. Schneider. 1995. Rapid Degradation of AU-rich element (ARE) mRNAs is activated by ribosome transit and blocked by secondary structure at any position 5′ to the ARE. Mol. Cell. Biol. 15:6331.
47. Malter, J. S. 1998. Posttranscriptional regulation of mRNAs important in T cell function. Adv. Immunol. 68:1.
48. Suarez, A., L. Mozo, A. Gayo, J. Zamorano, and C. Gutierrez. 1997. Requirement of a second signal via protein kinase C or protein kinase A for maximal expression of CD40 ligand: involvement of transcriptional and posttranscriptional mechanisms. Eur. J. Immunol. 27:2822.
49. Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659.
50. Korthauer, U., D. Graf, H. W. Mages, F. Briere, M. Padayachee, S. Malcolm, A. G. Ugazio, L. D. Notarangelo, R. J. Levinsky, and R. A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539.
51. Dilloo, D., M. Brown, M. Roskrow, W. Zhong, M. Holladay, W. Holden, and M. Brenner. 1997. CD40 ligand induces an antileukemia immune response in vivo. Blood 90:1927.
52. Mackey, M. F., J. R. Gunn, P. P. Ting, H. Kikutani, G. Dranoff, R. J. Noelle, and R. J. J. Barth. 1997. Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154. Cancer Res. 57:2569.
53. van Kooten, C., and J. Banchereau. 1997. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9:330.